Chapter 11- Hemolytic Anemias Flashcards
Hereditary spherocytosis
Pathologic Cells
RBCs, destroyed via hemolysis
Hereditary spherocytosis
Patients
1:2,000 individuals from Northern European Ancestry
Hereditary spherocytosis
Unique Features
Autosomal dominant
mutations in RBC membrane proteins, weak RBCs are
removed by spleen, manifests with anemia & splenomegaly, jaundice, RBCs lack central pallor
Hereditary spherocytosis
Prognosis
Variable severity, most have minor anemia, possibly complicated by
parvovirus B19 infection (aplastic crisis), splenectomy may be Tx. for severely affected patients
Sickle cell anemia
Pathologic Cells
RBCs, destroyed by hemolysis
Sickle cell anemia
Patients
8% of African Americans are heterozygotes (trait), 1:600 are homozygotes (have anemia)
Sickle cell anemia
Unique Features
Autosomal recessive betaglobin mutation in the RBC hemoglobin, makes RBCs prone to thrombosis, exacerbated by: blood is sluggish (spleen, marrow), dehydration, inflammation
Sickle cell anemia
Prognosis
Heterozygotes are asymptomatic and homozygotes express the condition, 50% of homozygotes live past their 50s, death is most commonly from a stroke or acute chest syndrome
α-thalassemia
Pathologic Cells
RBCs, destroyed
via hemolysis
α-thalassemia
Patients
Individuals from:
Mediterranean,
Africa, Southeast
Asia
α-thalassemia
Unique Features
Both cause early RBC hemolysis and damage RBC precursors in marrow. α-thalassemia results from α-globin mutation and damages RBCs due to unpaired β-globin
α-thalassemia
Prognosis
lethal in utero (4/4 mutations) or
asymptomatic carrier (1/4
mutations)
β-thalassemia (Minor/Major)
Pathologic Cells
RBCs, destroyed
via hemolysis
β-thalassemia (Minor/Major)
Patients
Individuals from:
Mediterranean,
Africa, Southeast
Asia
β-thalassemia (Minor/Major)
Unique Features
Both cause early RBC
hemolysis and damage RBC precursors in marrow. α-thalassemia results from α-globin mutation and damages
RBCs due to unpaired β-globin
(vice versa for β-thalassemia).